Qaialdo
Active substance: spironolactone
spironolactone
Centralised EU authorisationActive
Marketing holder: Lipomed GmbH
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 30 |
|
| US 192 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-36ed-7c17-a6cf-330a4b5f905c,01a120c3-36fb-7f6f-8946-17856b80b263,01a120c3-3b43-72aa-a2c8-328b002b4f69,01a120c3-4b03-7045-8d96-3bf9d129b164,01a120c3-4b0a-7e85-b610-7c9dab52f578;count=23 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2728-7a05-a215-b7e0783aaddb,01a1208c-2742-7991-a951-d55c70a5f060,01a1208c-2953-764f-87eb-e462fc67b465,01a1208c-3506-7528-8bab-3c35d6ce9595,01a1208c-4aef-7e5d-a2b2-510905210553;count=179 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- EMEA/H/C/005535
- Registration status
- Active
- ATC code
- C03DA01
- product · EMA · EMEA/H/C/005535 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/005535 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/005535 · Verified 2026-10-09